Q2 2026 saw 7.3% revenue growth, adjusted EPS of $2.58, and strong cash flow from operations. Full-year guidance was raised across revenue, EPS, and operating income, with all major segments showing improved performance.Original document: CVS Health Corporation [CVS] Slides Release — Aug. 5 2026Thi…
Q2 2026 saw 7.3% revenue growth, adjusted EPS of $2.58, and strong cash flow from operations. Full-year guidance was raised across revenue, EPS, and operating income, with all major segments showing improved performance.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.